Mark Robert Bray

2 Patents

• US123257002025

  Crystal Form S4 of the PLK4 Inhibitor (1r,2s)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)-1 H-imidazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one Fumarate

  UNIVERSITY HEALTH NETWORK

  0 cites
• US117664372023

  Combination Therapies for Inhibition of TTK Protein Kinase

  UNIVERSITY HEALTH NETWORK

  0 cites